Total Payments
$1.0M
2024 Payments
$229,970
Companies
47
Transactions
2,402
Medicare Patients
139
Medicare Billing
$15,330
Payment Breakdown by Category
Other$750,534 (73.0%)
Consulting$120,888 (11.8%)
Food & Beverage$77,602 (7.6%)
Travel$70,411 (6.9%)
Research$7,293 (0.7%)
Education$741.47 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $703,644 | 242 | 68.5% |
| Consulting Fee | $120,888 | 38 | 11.8% |
| Food and Beverage | $77,602 | 1,815 | 7.6% |
| Travel and Lodging | $70,411 | 273 | 6.9% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $25,140 | 12 | 2.4% |
| Honoraria | $21,750 | 12 | 2.1% |
| Unspecified | $7,293 | 1 | 0.7% |
| Education | $741.47 | 9 | 0.1% |
Payments by Type
General
$1.0M
2,401 transactions
Research
$7,293
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $134,228 | 186 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $124,583 | 253 | $0 (2024) |
| Galderma Laboratories, L.P. | $114,722 | 302 | $0 (2024) |
| GENZYME CORPORATION | $109,519 | 95 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $92,999 | 126 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $80,528 | 79 | $0 (2024) |
| Dermavant Sciences, Inc. | $77,407 | 124 | $0 (2024) |
| Celgene Corporation | $64,467 | 118 | $0 (2019) |
| Lilly USA, LLC | $56,189 | 89 | $0 (2024) |
| PFIZER INC. | $45,884 | 122 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $229,970 | 398 | Regeneron Healthcare Solutions, Inc. ($50,287) |
| 2023 | $358,820 | 498 | Dermavant Sciences, Inc. ($54,408) |
| 2022 | $125,535 | 320 | Amgen Inc. ($35,609) |
| 2021 | $71,168 | 233 | Amgen Inc. ($30,676) |
| 2020 | $62,627 | 261 | Galderma Laboratories, L.P. ($20,431) |
| 2019 | $90,087 | 273 | Celgene Corporation ($33,472) |
| 2018 | $62,686 | 263 | Celgene Corporation ($30,320) |
| 2017 | $26,577 | 156 | PFIZER INC. ($19,602) |
All Payment Transactions
2,402 individual payment records from CMS Open Payments — Page 1 of 97
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Galderma Laboratories, L.P. | — | Consulting Fee | Cash or cash equivalent | $4,525.00 | General |
| 12/20/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: DERMATOLOGY | ||||||
| 12/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.09 | General |
| Category: Immunology | ||||||
| 12/19/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: Dermatology | ||||||
| 12/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $7.80 | General |
| Category: Inflammation | ||||||
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.12 | General |
| Category: Immunology | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: Immunology | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $2.75 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: ACNE | ||||||
| 12/14/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Consulting Fee | Cash or cash equivalent | $5,250.00 | General |
| Category: Dermatology | ||||||
| 12/14/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $134.33 | General |
| Category: Dermatology | ||||||
| 12/14/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $115.54 | General |
| Category: Dermatology | ||||||
| 12/14/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $26.13 | General |
| 12/14/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $23.13 | General |
| 12/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/13/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $51.70 | General |
| Category: Dermatology | ||||||
| 12/13/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $32.12 | General |
| 12/13/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $19.60 | General |
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $105.03 | General |
| Category: Immunology | ||||||
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Immunology | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.56 | General |
| Category: Immunology | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $0.91 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PSOSA (PSORIASIS SPECIAL AREAS) - A US-BASED SINGLE-ARM PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY OF NAIL AND SCALP PSORIASIS IMPROVEMENT IN PATIENTS TREATED WITH IXEKIZUMAB | Eli Lilly and Company | $7,293 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 46 | 57 | $18,526 | $5,118 |
| 2022 | 4 | 64 | 83 | $25,110 | $7,594 |
| 2021 | 1 | 13 | 13 | $3,172 | $1,172 |
| 2020 | 1 | 16 | 16 | $3,439 | $1,447 |
Total Patients
139
Total Services
169
Medicare Billing
$15,330
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 23 | $8,464 | $2,349 | 27.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $5,886 | $1,542 | 26.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 16 | $4,176 | $1,227 | 29.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 28 | $6,892 | $2,190 | 31.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 15 | 21 | $6,272 | $2,010 | 32.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $6,322 | $1,995 | 31.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 20 | 20 | $5,624 | $1,398 | 24.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 13 | 13 | $3,172 | $1,172 | 36.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 16 | 16 | $3,439 | $1,447 | 42.1% |
About Dr. Amy Spizuoco, D.O
Dr. Amy Spizuoco, D.O is a Dermatology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2010. The National Provider Identifier (NPI) number assigned to this provider is 1285952515.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amy Spizuoco, D.O has received a total of $1.0M in payments from pharmaceutical and medical device companies, with $229,970 received in 2024. These payments were reported across 2,402 transactions from 47 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($703,644).
As a Medicare-enrolled provider, Spizuoco has provided services to 139 Medicare beneficiaries, totaling 169 services with total Medicare billing of $15,330. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location New York, NY
- Active Since 05/11/2010
- Last Updated 01/28/2020
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1285952515
Products in Payments
- DUPIXENT (Biological) $200,775
- Otezla (Drug) $198,122
- Sotyktu (Drug) $92,643
- AKLIEF (Drug) $78,557
- VTAMA (Drug) $77,265
- OLUMIANT (Drug) $45,352
- DUOBRII (Drug) $38,186
- EUCRISA (Drug) $37,987
- Zoryve (Drug) $34,377
- EPIDUO FORTE (Drug) $22,749
- AMZEEQ (Drug) $19,644
- TALTZ (Drug) $8,089
- Olumiant (Drug) $7,301
- Seysara (Drug) $6,336
- ZILXI (Drug) $5,951
- Mupirocin Cream (Drug) $4,416
- SEYSARA (Drug) $4,297
- YCANTH (Drug) $3,560
- SKYRIZI (Biological) $1,721
- OPZELURA (Drug) $1,495
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in New York
David Cohen, M.d, M.D
Dermatology — Payments: $3.1M
Dermatology $3.1M
Dr. Amy Wechsler, M.d, M.D
Dermatology — Payments: $2.8M
Dermatology $2.8M
Dr. Alexandra Golant, M.d, M.D
Dermatology — Payments: $2.7M
Dermatology $2.7M
Emma Guttman, Md, MD
Dermatology — Payments: $2.2M
Dermatology $2.2M
Dr. Joshua Zeichner, Md, MD
Dermatology — Payments: $2.1M
Dermatology $2.1M
Dr. Mark Lebwohl
Dermatology — Payments: $2.0M
Dermatology $2.0M